Spero Therapeutics Inc (SPRO) has fallen 0.92% Wednesday In Premarket Trading

Spero Therapeutics Inc (SPRO) has fallen Wednesday morning, with the stock declining -0.92% in pre-market trading to 1.08. SPRO's short-term technical score of 1 indicates that the stock has traded less bullishly over the last month than 99% of stocks on the market. In the Biotechnology industry, which ranks 123 out of 146 industries, the stock ranks higher than 1% of stocks. Spero Therapeutics Inc has fallen 3.54% over the past month, closing at $1.13 on October 18. During this period of time, the stock fell as low as $1.00 and as high as $1.29. SPRO has an average analyst recommendation of Strong Buy. The company has an average price target of $6.00.

SPRO has an Overall Score of 37. Find out what this means to you and get the rest of the rankings on SPRO!

See Full SPRO Report

Spero Therapeutics Inc has a Long-Term Technical rank of 17. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 83% of the market scoring higher. In the Biotechnology industry which is number 130 by this metric, SPRO ranks better than 130% of stocks.

Important Dates for Investors in SPRO:

-Spero Therapeutics Inc is set to release earnings on 2024-02-11. Over the last 12 months, the company has reported EPS of $0.17. -We do not have a set dividend date for Spero Therapeutics Inc at this time. Click Here To Get The Full Report on Spero Therapeutics Inc (SPRO)